Kiuru PS - Search Results

1

Short synthesis of 2-methoxyestradiol and 2-hydroxyestradiol.

Kiuru PS, Wähälä K. Kiuru PS, et al. Steroids. 2003 Apr;68(4):373-5. doi: 10.1016/s0039-128x(03)00035-7. Steroids. 2003. PMID: 12787899

2

Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.

Ziegler RG, Rossi SC, Fears TR, Bradlow HL, Adlercreutz H, Sepkovic D, Kiuru P, Wahala K, Vaught JB, Donaldson JL, Falk RT, Fillmore CM, Siiteri PK, Hoover RN, Gail MH. Ziegler RG, et al. Environ Health Perspect. 1997 Apr;105 Suppl 3(Suppl 3):607-14. doi: 10.1289/ehp.97105s3607. Environ Health Perspect. 1997. PMID: 9168003 Free PMC article.

3

Quantitative determination of estradiol fatty acid esters in human pregnancy serum and ovarian follicular fluid.

Vihma V, Adlercreutz H, Tiitinen A, Kiuru P, Wähälä K, Tikkanen MJ. Vihma V, et al. Clin Chem. 2001;47(7):1256-62. Clin Chem. 2001. PMID: 11427457

4

An isotope dilution gas chromatographic-mass spectrometric method for the simultaneous assay of estrogens and phytoestrogens in urine.

Adlercreutz H, Kiuru P, Rasku S, Wähälä K, Fotsis T. Adlercreutz H, et al. J Steroid Biochem Mol Biol. 2004 Dec;92(5):399-411. doi: 10.1016/j.jsbmb.2004.10.015. Epub 2005 Jan 8. J Steroid Biochem Mol Biol. 2004. PMID: 15698545

5

Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues.

Kärkkäinen J, Forsström T, Tornaeus J, Wähälä K, Kiuru P, Honkanen A, Stenman UH, Turpeinen U, Hesso A. Kärkkäinen J, et al. Scand J Clin Lab Invest. 2005;65(3):189-99. doi: 10.1080/00365510510013604. Scand J Clin Lab Invest. 2005. PMID: 16095048

6

Microwave-assisted synthesis of deuterium labeled estrogen fatty acid esters.

Kiuru PS, Wähälä K. Kiuru PS, et al. Steroids. 2006 Jan;71(1):54-60. doi: 10.1016/j.steroids.2005.08.001. Epub 2005 Sep 29. Steroids. 2006. PMID: 16198386

7

Design and synthesis of 2-arylbenzimidazoles and evaluation of their inhibitory effect against Chlamydia pneumoniae.

Keurulainen L, Salin O, Siiskonen A, Kern JM, Alvesalo J, Kiuru P, Maass M, Yli-Kauhaluoma J, Vuorela P. Keurulainen L, et al. J Med Chem. 2010 Nov 11;53(21):7664-74. doi: 10.1021/jm1008083. J Med Chem. 2010. PMID: 20932010

8

Synthesis of novel purpurealidin analogs and evaluation of their effect on the cancer-relevant potassium channel KV10.1.

Moreels L, Bhat C, Voráčová M, Peigneur S, Goovaerts H, Mäki-Lohiluoma E, Zahed F, Pardo LA, Yli-Kauhaluoma J, Kiuru P, Tytgat J. Moreels L, et al. PLoS One. 2017 Dec 8;12(12):e0188811. doi: 10.1371/journal.pone.0188811. eCollection 2017. PLoS One. 2017. PMID: 29220359 Free PMC article.

9

Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.

Keurulainen L, Siiskonen A, Nasereddin A, Kopelyanskiy D, Sacerdoti-Sierra N, Leino TO, Tammela P, Yli-Kauhaluoma J, Jaffe CL, Kiuru P. Keurulainen L, et al. Bioorg Med Chem Lett. 2015 May 1;25(9):1933-7. doi: 10.1016/j.bmcl.2015.03.027. Epub 2015 Mar 18. Bioorg Med Chem Lett. 2015. PMID: 25827525

10

A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amides.

Keurulainen L, Vahermo M, Puente-Felipe M, Sandoval-Izquierdo E, Crespo-Fernández B, Guijarro-López L, Huertas-Valentín L, de las Heras-Dueña L, Leino TO, Siiskonen A, Ballell-Pages L, Sanz LM, Castañeda-Casado P, Jiménez-Díaz MB, Martínez-Martínez MS, Viera S, Kiuru P, Calderón F, Yli-Kauhaluoma J. Keurulainen L, et al. J Med Chem. 2015 Jun 11;58(11):4573-80. doi: 10.1021/acs.jmedchem.5b00114. Epub 2015 May 19. J Med Chem. 2015. PMID: 25906200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page